|
|
24650 Industrial Boulevard Hayward, CA 94545 USA phone:(510) 782-7800 fax:(510) 782-7801
|
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| www.intarcia.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Generates new uses for drugs licensed from major pharmaceutical companies. |
 |
| Management |
| K. Alice Leung, President and Chief Executive Officer; James Ahlers, Vice President of Finance and Operations, Chief Financial Offier; Thomas Alessi, Ph.D., Vice President, Development and Manufacturing; David J. Franklin, Vice President, Commercial Operations; Kenneth Luskey, M.D., Vice President, Clinical Research; Barbara McClung, Vice President, General Counsel, Corporate Secretary; Janice Dahms, Executive Director, Product Development; Dick Ford, Executive Director, DUROS? Manufacturing; Robert Lemmon, Ph.D., Executive Director, Regulatory Compliance and Quality Assurance |
| |
|
|
| |
|
| Keywords |
| cancer, infectious disease, immunology, AllergyImmunology, InfectiousDisease |
|
|
|
| Description |
|
Intarcia Therapeutics, Inc. specializes in developing and systematically generating new uses for clinical-stage drugs licensed from major pharmaceutical companies. |
 |
| Technology / Differentiation |
| Intarcia now has several products in various stages of clinical development for use in treating patients with cancer, immunological disorders and infectious diseases in both the United States and Europe. |
 |
 |
|
|
|
|
|
|